Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Jnj crawled date : 2021 - 10 - 04 save search
Xencor and Janssen Unite Again in Second Bispecific Antibodies Agreement
Published: 2021-10-04 (Crawled : 22:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.98%
H: 0.63%
C: -0.48%
antibody
Bentley University Announces Vaccination Requirement for Home Indoor Athletic Events
Published: 2021-10-04 (Crawled : 20:00) - prnewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.4%
H: 0.78%
C: -0.18%
vaccine
Novavax Announces Leadership Appointment and Updates
Published: 2021-10-04 (Crawled : 20:00) - prnewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.4%
H: 0.78%
C: -0.18%
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
|
| O: 1.81%
H: 2.04%
C: -6.34%
COVID-19 Update: J&J to Request Booster Authorization, Merck Antiviral Review a Priority
Published: 2021-10-04 (Crawled : 17:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.98%
H: 0.63%
C: -0.48%
covid antiviral authorized covid-19
Global Molecular Diagnostics Markets Analysis & Forecasts, 2016-2020 & 2021-2026 with COVID-19 Impact Insights
Published: 2021-10-04 (Crawled : 16:00) - prnewswire.com
TMO | News | $541.52 -1.05% 0.61% 2.1M
|
Health Technology
|
| O: -0.2%
H: 0.52%
C: -0.45%
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: -0.02%
H: 0.26%
C: -0.69%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.98%
H: 0.63%
C: -0.48%
DHR | $236.36 -1.27% 0.0% 4.2M
|
Health Technology
|
| O: -0.19%
H: 0.62%
C: -1.05%
BDX | $233.15 0.41% 0.15% 890K
|
Health Technology
|
| O: -0.44%
H: 1.51%
C: -1.26%
ABT | News | $105.27 -0.6% -0.15% 7.3M
|
Health Technology
|
| O: -0.51%
H: 0.82%
C: -0.93%
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: -0.02%
H: 0.26%
C: -0.69%
covid molecular diagnostics molecular diagnostics diagnostic
Clinical Catch-Up: September 27-October 1
Published: 2021-10-04 (Crawled : 14:15) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.98%
H: 0.63%
C: -0.48%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.54%
H: 0.77%
C: 0.17%
New Analysis Presented by Janssen at United European Gastroenterology Week (UEGW) Demonstrates Long-Term Safety Profile for STELARA® (ustekinumab) in Older Patients Across Approved Indications
Published: 2021-10-04 (Crawled : 13:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.98%
H: 0.63%
C: -0.48%
europe order
Adamis Announces Appointment of Meera Desai, Ph.D., to Board of Directors
Published: 2021-10-04 (Crawled : 12:00) - globenewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.98%
H: 0.63%
C: -0.48%
NKTR | $1.3 -3.7% -3.85% 3.6M
|
Health Technology
|
| O: 2.74%
H: 1.58%
C: -1.58%
ADMP | $0.7751 0.86% 2.6% 120K
|
Health Technology
|
| O: 3.98%
H: 3.96%
C: 2.97%
Xencor Enters Global Collaboration and License Agreement With Janssen to Advance Plamotamab and XmAb CD28 Bispecific Antibody Combinations for the Treatment of Patients With B-Cell Malignancies
Published: 2021-10-04 (Crawled : 12:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.98%
H: 0.63%
C: -0.48%
XNCR | $18.98 -0.47% -0.47% 470K
|
Health Technology
|
| O: 2.87%
H: 5.64%
C: 5.37%
treatment collaboration antibody license t-cell
Active Pharmaceutical Ingredient (API) Market to Cross $357,005.7 Million Value by 2030, says P&S Intelligence
Published: 2021-10-04 (Crawled : 10:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.49%
H: 0.0%
C: -0.77%
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: 6.28%
H: 0.0%
C: -0.2%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.96%
H: 0.0%
C: 0.0%
TEVA | $12.78 -3.03% -0.24% 9M
|
Health Technology
|
| O: -1.95%
H: 2.51%
C: 0.73%
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: -0.28%
H: 0.49%
C: -1.16%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.83%
H: 1.0%
C: 0.15%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.98%
H: 0.63%
C: -0.48%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 0.1%
H: 1.02%
C: 0.37%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -1.53%
H: 1.05%
C: -1.29%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: 0.13%
H: 1.05%
C: -0.79%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.71%
H: 1.25%
C: -0.1%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.54%
H: 0.77%
C: 0.17%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: 1.28%
H: 0.83%
C: 0.82%
Addex to Present at the 10th International Meeting on Metabotropic Glutamate Receptors
Published: 2021-10-04 (Crawled : 06:00) - globenewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.98%
H: 0.63%
C: -0.48%
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.